Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Nitracrine MeSH Descriptor Data 2025


MeSH Heading
Nitracrine
Tree Number(s)
D03.633.300.046.250.650
Unique ID
D009564
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D009564
Scope Note
Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis.
Entry Term(s)
C-283
Ledakrin
Pharm Action
Antineoplastic Agents
Nucleic Acid Synthesis Inhibitors
Registry Numbers
712MLZ30SB
0
Related Numbers
4533-39-5
CAS Type 1 Name
1,3-Propanediamine, N,N-dimethyl-N'-(1-nitro-9-acridinyl)-
Previous Indexing
Acridines (1971-1974)
Dimethylamines (1973-1974)
Nitro Compounds (1972-1974)
Public MeSH Note
91; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80
Online Note
use NITRACRINE to search C 283 1975-84
History Note
91(85); was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80
Date Established
1991/01/01
Date of Entry
1974/11/19
Revision Date
2016/05/31
Nitracrine Preferred
C-283 Narrower
Ledakrin Narrower
page delivered in 0.127s